{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:17:46Z","timestamp":1787015866888,"version":"build-2736575974"},"reference-count":53,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T00:00:00Z","timestamp":1441238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Galderma Laboratorium GmbH, Germany"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycoses"],"published-print":{"date-parts":[[2015,10]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    Although topical antifungal therapies for treating onychomycosis are available, the cure rate is unsatisfactorily low with a simultaneously high risk of recurrence. One reason might be the formation of dormant fungal cells by the pathogen, known as spores, which can survive in the affected nail keratin, thereby evading the effect of antifungal drugs. In this\n                    <jats:italic>in\u00a0vitro<\/jats:italic>\n                    study, the ability of amorolfine and four other antimycotics (ciclopirox, bifonazole, terbinafine and fluconazole) to kill microconidia of the dermatophyte\n                    <jats:italic>Trichophyton rubrum<\/jats:italic>\n                    , chlamydospores of the dermatophyte\n                    <jats:italic>Epidermophyton floccosum<\/jats:italic>\n                    and blastospores of the yeast\n                    <jats:italic>Candida albicans<\/jats:italic>\n                    was extensively studied as these fungi occur predominantly in onychomycosis. The effectiveness of all five antimycotics depended on the drug concentration and the incubation time: a concentration of 10\u20131000 times the minimum inhibitory concentration against growing hyphae cells is needed to exert a sporicidal action. Amorolfine and ciclopirox showed the same sporicidal efficacy and kinetics for all three varieties of spores. Both were more effective than fluconazole and bifonazole against microconidia and chlamydospores as well as slightly more potent against chlamydospores and blastospores than terbinafine after 4\u00a0days of incubation and at concentrations of \u226510\u00a0\u03bcg\u00a0ml\n                    <jats:sup>\u22121<\/jats:sup>\n                    . Finally, sporicidal activity on the tested strains was demonstrated for all five different antimycotics used for onychomycosis treatment.\n                  <\/jats:p>","DOI":"10.1111\/myc.12369","type":"journal-article","created":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T02:57:28Z","timestamp":1441249048000},"page":"610-619","source":"Crossref","is-referenced-by-count":18,"title":["Sporicidal effect of amorolfine and other antimycotics used in the therapy of fungal nail infections"],"prefix":"10.1111","volume":"58","author":[{"given":"Hans P.","family":"Seidl","sequence":"first","affiliation":[{"name":"Dermatologische Klinik TU M\u00fcnchen M\u00fcnchen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"J\u00e4ckel","sequence":"additional","affiliation":[{"name":"Galderma Laboratorium GmbH Medical Department D\u00fcsseldorf Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Galderma Laboratorium GmbH Medical Department D\u00fcsseldorf Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schaller","sequence":"additional","affiliation":[{"name":"Universit\u00e4tshautklinik T\u00fcbingen T\u00fcbingen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Borelli","sequence":"additional","affiliation":[{"name":"Universit\u00e4tshautklinik T\u00fcbingen T\u00fcbingen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Polak","sequence":"additional","affiliation":[{"name":"Spitzrainweg Aesch\/BL Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,9,3]]},"reference":[{"key":"e_1_2_7_2_1","first-page":"C1492","article-title":"Onychomykose","volume":"97","author":"Abeck D","year":"2000","journal-title":"Deutsches \u00c4rzteblatt"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.12788\/j.sder.0014"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2012.681779"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2005.01284.x"},{"key":"e_1_2_7_6_1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/iai.18.2.479-486.1977","article-title":"Factors affecting germination of trichophyton mentagrophytes arthrospores","volume":"18","author":"Hashimoto T","year":"1977","journal-title":"Infect Immun"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0933-7407.2003.00932.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2004.00975.x"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.46474-0"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1988.tb04418.x"},{"key":"e_1_2_7_11_1","first-page":"224","article-title":"Ciclopirox und Terbinafin bei Dermatophyten \u2013 Auswirkungen auf die Behandlung der Onychomykose","volume":"9","author":"Seebacher C","year":"2003","journal-title":"Derm"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1159\/000142334"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.3109\/13693780802577892"},{"key":"e_1_2_7_14_1","first-page":"242","article-title":"Experience with nail lacquers containing amorolfine 5% and ciclopirox 8% in patients with onychomycosis","volume":"18","author":"Halmy K","year":"2004","journal-title":"JEADV"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70492-X"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1989.tb00907.x"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2013.06.011"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2010.07499_supp.x"},{"key":"e_1_2_7_19_1","first-page":"12","article-title":"Onychomykosen: Steigerung der Therapieeffizienz durch konsequent durchgef\u00fchrte Kombinationstherapie","volume":"3","author":"Nolting C","year":"2001","journal-title":"Skin & More"},{"key":"e_1_2_7_20_1","first-page":"133","article-title":"Standortbestimmung in der Antimykotika\u2010Therapie","volume":"9","author":"Nolting KS","year":"2003","journal-title":"Derm"},{"key":"e_1_2_7_21_1","first-page":"5","article-title":"Nagel Batrafen\u00ae \u2013 eine \u00dcbersicht","author":"Tietz HJ","year":"1999","journal-title":"\u00c4rztliche Praxis Dermatologie"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0353.2002.02606.x"},{"key":"e_1_2_7_23_1","first-page":"485","article-title":"Einfluss und Wirkung von Ciclopirox auf Pilze und Bakterien","volume":"11","author":"Tietz HJ","year":"2005","journal-title":"Derm"},{"key":"e_1_2_7_24_1","first-page":"331","article-title":"Goldstandard der Onychomykose\u2010Therapie: Terbinafin und Ciclopirox","volume":"12","author":"Tietz HJ","year":"2006","journal-title":"Derm"},{"key":"e_1_2_7_25_1","first-page":"272","article-title":"Pilzinfektionen im Fu\u00dfbereich. Von der Tinea pedis bis zur Onychomykose","volume":"7","author":"Ulbricht H","year":"2002","journal-title":"Haut"},{"key":"e_1_2_7_26_1","first-page":"16","article-title":"Ohne Mykologie keine Dermatologie","volume":"27","author":"Ulbricht H","year":"2003","journal-title":"MedReport"},{"key":"e_1_2_7_27_1","first-page":"36","article-title":"Pilze haben immer Saison","author":"Wasielewski S","year":"2005","journal-title":"PTA heute, Sonderheft Interpharm"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12461067"},{"key":"e_1_2_7_29_1","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi","author":"National Committee for Clinical Laboratory Standards","year":"2008"},{"key":"e_1_2_7_30_1","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts","author":"National Committee for Clinical Laboratory Standards","year":"2008"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001050050812"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/mmy.39.4.321.328"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1139\/m79-056"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/02681219280000191"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb06929.x"},{"key":"e_1_2_7_36_1","first-page":"S17","article-title":"Amorolfine nail lacquer: a novel formulation","volume":"4","author":"Marty JPL","year":"1995","journal-title":"JEADV"},{"key":"e_1_2_7_37_1","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1067\/mjd.2000.109072","article-title":"Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis","volume":"43","author":"Bohn M","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2004.01090.x"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.10.4817-4819.2003"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1996.tb00082.x"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198529040-00002"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1992.tb00273.x"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1993.tb00696.x"},{"key":"e_1_2_7_44_1","unstructured":"MensingH Sch\u00f6pfE Pfister\u2010WarthaA PolakA BisphamK ClarkeC.Penetration of amorolfine into the nails of patients with onychomycosis.EADV Barcelona1988 Poster."},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1992.tb00274.x"},{"key":"e_1_2_7_46_1","first-page":"17","article-title":"A randomised comparison of nail surface remanence of three nail lacquers, containing amorolfine 5%, ciclopirox 8% or tioconazole 28%, in healthy volunteers","volume":"26","author":"Sidou F","year":"2004","journal-title":"Int J Tissue React"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1159\/000247612"},{"key":"e_1_2_7_48_1","unstructured":"ZaugM.Amorolfin nail lacquer: once\u2010weekly application in onychomycosis. Amorolfin Symposium: 10th Regional Conference on Dermatology1993; Suppl.JAMA SEA."},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03545.x"},{"key":"e_1_2_7_50_1","unstructured":"Aventis Pharmaceuticals Inc. Kansas City US.Summary of Product Characteristics PenlacTMNail Lacquer (Ciclopirox) Topical Solution 8% prescribing information as of December 1999."},{"key":"e_1_2_7_51_1","unstructured":"Sanofi\u2010Aventis Deutschland GmbH Frankfurt am Main Germany.Summary of Product Characteristics Nagel Batrafen\u00ae information as of June 2012."},{"key":"e_1_2_7_52_1","unstructured":"Winthrop Arzneimittel GmbH Frankfurt am Main Germany.Summary of Product Characteristics Ciclopirox Winthrop\u00aeNagellack information as of July 2014."},{"key":"e_1_2_7_53_1","unstructured":"Food and Drug Administration Rockville US.FDA\u2010Warning\u2010Letter. Ciclopirox (Loprox\u00aeCream\/Lotion Medicis Pharm. Corp.) released by FDA 7 March 2000."},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1992.tb00270.x"}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fmyc.12369","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/myc.12369","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T20:07:19Z","timestamp":1696190839000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/myc.12369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,3]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.1111\/myc.12369"],"URL":"https:\/\/doi.org\/10.1111\/myc.12369","archive":["Portico"],"relation":{},"ISSN":["0933-7407","1439-0507"],"issn-type":[{"value":"0933-7407","type":"print"},{"value":"1439-0507","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,3]]}}}